DCF — NEW YORK EYE AND EAR INFIRMARY
Enterprise Value: $-99.8M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-99.8M
Enterprise Value
$-33.4M
PV of Cash Flows
$-66.4M
PV of Terminal Value
$-107.0M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $116.2M | $-5.2M | -5.0% | $-10.1M | $-9.2M |
| Year 2 | $119.7M | $-4.2M | -4.0% | $-9.3M | $-7.7M |
| Year 3 | $123.3M | $-3.1M | -3.0% | $-8.3M | $-6.2M |
| Year 4 | $127.0M | $-2.5M | -2.0% | $-7.9M | $-5.4M |
| Year 5 | $130.8M | $-2.3M | -2.0% | $-7.8M | $-4.9M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-99.8M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$112.8M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.0500000017724592
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5